News

The World Health Organization has declared COVID-19 a global emergency.

During this challenging time, our priority has been the protection of the health and wellbeing of our employees. We have also been working hard to minimise any disruption of services to our clients, and to reduce risk to our business partners.

We have been monitoring the global COVID-19 pandemic since the beginning of this year, formalising business continuity plans, and developing and implementing strong processes and controls to minimise the risk to our employees’ health and to prevent significant disruption to our operations.

Many years of high investment by the knoell group in IT infrastructure means that we are in an excellent position for all of our staff to continue working, from home, with fully secure connections to all systems necessary to fulfil commitments to our clients.

We want to assure you that we remain available to deliver your projects at this extraordinary time.

Evolving situation

The management team at Cyton Triveritas are keeping abreast of updated guidance from the UK Government, Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and other national and global health organisations. We recognise that the situation is continually evolving, and have taken proactive steps to mitigate risk while maintaining business continuity.

We are currently assessing the potential impact of COVID-19 on timelines and deliverables which may vary across our service offerings and regions, and will keep our valued clients and business partners fully informed. We will continue to provide overall updates on the situation and will contact clients individually about any particular issues with their projects.

We are committed to maintaining the quality of service expected from Cyton Triveritas during these critical and unprecedented times.

Please feel free to reach out to your Cyton Triveritas contact if you have any questions, comments or concerns.
Best regards and stay safe,

Helen Edwards & Karolina Bate
Managing Directors Cyton Triveritas

Cyton Biosciences is excited to announce that Triveritas has become part of the knoell group of companies.

Cyton was founded in Bristol, UK, in 1997, and has grown over the last 20 years to be a leading regulatory consultancy in animal health.

Triveritas was founded in 2000, in Cumbria, UK, and has similarly expanded to become an internationally recognised and highly regarded full service veterinary contract research organisation.

Cyton and Triveritas share the same core values: quality, expertise and flexibility, offering client companies the highest quality product development support, based on our years of acquired experience and strong technical knowledge.

The arrival of Triveritas in the knoell group represents an expansion and strengthening of our service provision in the animal health industry and will enhance our services for clients. Both Cyton and Triveritas have over two decades’ experience supporting client companies in the areas of veterinary regulatory affairs, scientific writing and global project management.

Triveritas brings to the group a proven track record to conduct global veterinary clinical trials to GCP and VICH standards.

Our clients will benefit from a wider range of services across more territories – and the flexibility and responsiveness of our expertise on which we pride ourselves will not be lost.

Cyton and Triveritas will both continue to operate from their existing offices; contact details will not change.

We would like to thank all our clients for entrusting their projects to us over the years, and for their valued custom.

We look forward to this new chapter in our company’s development and most importantly, providing our clients with the expertise and support for their projects for many years to come.

Cyton and Triveritas will be hosting a joint stand at the Animal Health Investment Forum in London between February 24-26th; meet us there.

If you would like to discuss any of these changes or have any questions, please contact:

Julian Braidwood (julian.braidwood@triveritas.com),

Sue Lester (sue.lester@triveritas.com)

Richard Hunter (richard.hunter@triveritas.com)

or Mel Munro (mel.munro@triveritas.com). t + 44 (0) 845 123 28 88 www.triveritas.com  or via email info@triveritas.com

Download this release as a .doc file